RT Journal Article
SR Electronic
T1 Treatment strategies for hepatitis C: Making the best of limited options
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 476
OP 480
VO 67
IS 7
A2 Wilke, William S.
A1 McHutchison, John G.
A1 Younossi, Zobair
YR 2000
UL http://www.ccjm.org/content/67/7/476.abstract
AB Data from two recent major trials suggest that several changes in clinical practice would benefit hepatitis C patients, including viral genotyping to more accurately determine the duration of therapy, and timely RNA measurement to predict treatment response. Although the combination of interferon alfa-2b and ribavirin therapy has proved superior to interferon alone, the success of interferon-based therapies in eradicating hepatitis C is limited, and the quest for new strategies and treatments continues.